When you see each
patient a million
times a day...

...You see the
bigger picture.

Every second, our FDA-cleared AI-based ecosystem compares 20+ physiological signals* from a wearable biosensor with data from millions of other chronic patients. The result? Powerful pattern recognition designed to help clinicians predict and prevent deterioration before it happens.

When you see each patient a million times a day... You see the bigger picture.

Every second, our FDA-cleared AI-based ecosystem compares 20+ physiological signals* from a wearable biosensor with data from millions of other chronic patients. The result? Powerful pattern recognition that helps predict and prevent deterioration before it happens.

We're powering personally predictive care...
so everyone can see better outcomes.

What if patients suffering from heart failure, COPD, chronic pain, or cancer could spend less time in hospitals and more time feeling confident and cared for at home? What if networks, clinicians, and payers could turn fewer readmissions into a higher level of care for all? And what if drug companies could more dramatically demonstrate, in real-time, the physiological impact and value of pharmacotherapy candidates?

At Biofourmis, we use patient physiology data and advanced analytics to turn those "what-ifs" into "ah-has" for some of the world's most respected healthcare providers and pharmaceutical companies—collaborators like Novartis, Chugai, Brigham and Women's Hospital, and Mayo Clinic that use our clinically validated, predictive platform to more precisely manage, intervene, and treat chronic patients in a way that's proactive and liberating. That's the power of personally predictive care.

Get To Know Us

The Biovitals® platform shows you more than patient data.
It can help show you patient futures.

Our Biovitals® platform collects and interprets vast amounts of population metadata and compares it to real-time patient physiological signals to provide a clearer picture of chronic patients and their disease trajectory—a real-time picture designed to help clinicians predict and prevent serious medical events. Its actionable insights powered by machine learning, deep neural networks, and a clinical-grade Everion® wearable.

See How Biovitals® Works

Predict and prevent costly medical events with a modular, user-friendly platform.

Biovitals® delivers actionable information by bringing disease, data, machine-learning, and clinical-grade hardware together in one customizable ecosystem. Learn how we can tailor Biovitals® to improve real-world outcomes for the unique needs of health systems, payers and pharmaceutical companies.

Hospitals Icon Created with Sketch.
Payors Icon Created with Sketch.
Pharma Icon Created with Sketch.

Health Systems

  • Improve clinical outcomes by reducing readmissions and ED visits
  • Improve workflow efficiencies, care team capacity and ongoing communication with patients
  • Realize more rapid personalized treatment and communication for efficient management of patients with complex chronic conditions

Payers

  • Reduce overall healthcare expenditures while improving clinical outcomes
  • Improve quality of life for members with complex chronic conditions
  • Deliver members more targeted and timely intervention and engagement support based on their personalized needs

Pharmaceutical Companies

  • Augment drug efficacy and outcomes using drug + digital intervention
  • Accelerate development time frames by accelerating clinical trials using digital tools
  • Increase patient share, adherence, and engagement
  • Increase reimbursements and/or value-based payments
Hospitals Icon Created with Sketch.

Health Systems

Payors Icon Created with Sketch.

Payers

Pharma Icon Created with Sketch.

Pharmaceutical Companies

Clinical evidence and science guides everything we do

Around the world and across multiple collaborations and studies, our Biovitals® Platform is helping clinical teams see patients like never before.

Collaborators and Investors

We're proud to collaborate with some of the world's most respected healthcare organizations, research hospitals, and biopharma companies. Together, we're improving patient outcomes, advancing clinical research, reducing healthcare costs, and accelerating drug research and development.

COLLABORATORS

INVESTORS

Biofourmis in the news.

Let's get you up to speed.

Biofourmis Named to Fierce 15

Digital monitoring startup and Fierce 15 winner Biofourmis is trying to pair remote monitoring with needed drugs to better monitor patients' health.

May 2, 2020

Digital Therapeutics Explained: DTx market trends & top companies delivering on the latest digital health opportunity

Digital therapeutics deliver evidence-based therapies via software — often in the form of consumer-facing mobile health apps — that replace or complement the existing treatment of a disease. They diverge from the broader digital health market in that they must be approved by regulatory bodies — and displaying proof-of-concept is at the core of their model.

December 18, 2019

A guide to connected health device and remote patient monitoring vendors

In an age when nearly everyone is digitally connected in some way – even many senior citizens, who are often characterized as technophobic – it only makes sense that the healthcare industry is seeing a lot of connected health devices and remote patient monitoring (RPM) technologies.

May 6, 2020

JPM20: Headlines from healthcare's biggest conference

SAN FRANCISCO—It's the last day of the conference, and as things wind down, there's plenty of exhaustion to go around from running to back-to-back meetings.

Here's a look at some of the news from the conference from our FierceHealthcare team:

April 16, 2020

Biofourmis News

Let's connect.

We're helping some of the most respected names in healthcare deliver measurably better outcomes. Let us show you what personally predictive care can do for your organization.

Contact Us